PCM
RVLP

Penserra Capital Management’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Penserra Capital Management’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,440
Closed -$4K – 1606
2021
Q3 		$4K Buy
1,440
+10
+0.7% +$34 ﹤0.01% 1425
2021
Q2 		$4K Buy
1,430
+10
+0.7% +$31 ﹤0.01% 1324
2021
Q1 		$4K Sell
1,420
-55
-4% -$226 ﹤0.01% 1093
2020
Q4 		$6K Buy
1,475
+931
+171% +$5.37K ﹤0.01% 980
2020
Q3 		$2K Buy
+544
New +$3.13K ﹤0.01% 914

Other funds holding RVLP

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
RA
Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Penserra Capital Management's RVLP Position: Q4 2021 in Review

Penserra Capital Management sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2021, closing a stake of 1,440 shares — an estimated $4K sold.

Penserra Capital Management first reported a position in RVLP in Q3 2020 and held it in 5 quarters. The position peaked at $6K in Q4 2020. 31 funds tracked by Wall St. Rank hold RVLP as of Q4 2021.

  • Penserra Capital Management reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2021 after selling out during the quarter.
  • Penserra Capital Management sold 1,440 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2021, an estimated $4K.
  • Penserra Capital Management first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q3 2020 and held it in 5 quarters.
  • Penserra Capital Management's RVL Pharmaceuticals plc Ordinary Shares position peaked at $6K in Q4 2020.
  • 31 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.